Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:19380447rdf:typepubmed:Citationlld:pubmed
pubmed-article:19380447lifeskim:mentionsumls-concept:C0030705lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0237401lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0087111lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0008976lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0002871lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0034656lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C1511726lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0937950lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C0936012lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C2349200lld:lifeskim
pubmed-article:19380447lifeskim:mentionsumls-concept:C1709595lld:lifeskim
pubmed-article:19380447pubmed:issue17lld:pubmed
pubmed-article:19380447pubmed:dateCreated2009-6-9lld:pubmed
pubmed-article:19380447pubmed:abstractTextAlthough numerous clinical trials have demonstrated the efficacy and tolerability of erythropoiesis-stimulating agents (ESAs) in patients with chemotherapy-induced anemia (CIA), results of some recent trials and one meta-analysis have suggested that ESAs may negatively impact survival and/or disease control in patients with cancer.lld:pubmed
pubmed-article:19380447pubmed:commentsCorrectionshttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:languageenglld:pubmed
pubmed-article:19380447pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:citationSubsetIMlld:pubmed
pubmed-article:19380447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:19380447pubmed:statusMEDLINElld:pubmed
pubmed-article:19380447pubmed:monthJunlld:pubmed
pubmed-article:19380447pubmed:issn1527-7755lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:GlaspyJohn...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:OsterborgAnde...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:LudwigHeinzHlld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:Vansteenkiste...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:CrawfordJeffr...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:HenryDavid...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:FleishmanAlex...lld:pubmed
pubmed-article:19380447pubmed:authorpubmed-author:BridgesKenKlld:pubmed
pubmed-article:19380447pubmed:issnTypeElectroniclld:pubmed
pubmed-article:19380447pubmed:day10lld:pubmed
pubmed-article:19380447pubmed:volume27lld:pubmed
pubmed-article:19380447pubmed:ownerNLMlld:pubmed
pubmed-article:19380447pubmed:authorsCompleteYlld:pubmed
pubmed-article:19380447pubmed:pagination2838-47lld:pubmed
pubmed-article:19380447pubmed:dateRevised2009-11-23lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:meshHeadingpubmed-meshheading:19380447...lld:pubmed
pubmed-article:19380447pubmed:year2009lld:pubmed
pubmed-article:19380447pubmed:articleTitlePooled analysis of individual patient-level data from all randomized, double-blind, placebo-controlled trials of darbepoetin alfa in the treatment of patients with chemotherapy-induced anemia.lld:pubmed
pubmed-article:19380447pubmed:affiliationWilhelminenspital, Department of Medicine I, Center for Oncology and Hematology, Pavillion 23, Montleartstrasse 37, Vienna 1160, Austria. heinz.ludwig@wienkav.atlld:pubmed
pubmed-article:19380447pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:19380447pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
pubmed-article:19380447pubmed:publicationTypeMeta-Analysislld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19380447lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19380447lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:19380447lld:pubmed